Showing results (1381-1390 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|December 16, 2017
Alterations in gene expression in vitamin D-deficiency: Down-regulation of liver Cyp7a1 and renal Oat3 in miceHolly P Quach, Keumhan Noh, Stacie Y Hoi, et al.Biopharmaceutics & Drug Disposition|November 1, 1987
Etintidine-theophylline interaction study in humansS M Huang, H S Weintraub, T B Marriott, et al.Biopharmaceutics & Drug Disposition|September 3, 2017
Impact of enzalutamide and its main metabolite N-desmethyl enzalutamide on pharmacokinetically important drug metabolizing enzymes and drug transportersJohanna Weiss, Jutta Kocher, Corina Mueller, et al.Biopharmaceutics & Drug Disposition|February 23, 2018
Evaluation of the metabolic capability of primary human hepatocytes in three-dimensional cultures on microstructural platesSatoshi Koyama, Hiroshi Arakawa, Manabu Itoh, et al.Biopharmaceutics & Drug Disposition|February 24, 2018
Differences in nonclinical pharmacokinetics between species and prediction of human pharmacokinetics of TAK-272 (SCO-272), a novel orally active renin inhibitorTakuya Ebihara, Mitsuhiro Nishihara, Junzo Takahashi, et al.Biopharmaceutics & Drug Disposition|January 13, 2018
Bioactivity guided fractionation of methanolic extract of Terminalia arjuna for its CYP3A and CYP2D inhibition in rat liver microsomesAlice Varghese, Prachi Saboo, Sarika WairkarBiopharmaceutics & Drug Disposition|December 7, 2018
Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailabilityNeha Maharao, Jurgen Venitz, Phillip M GerkBiopharmaceutics & Drug Disposition|November 2, 2019
Dasotraline as a selective cytochrome 2B6 inhibitor for reaction phenotypingXin Yang, Sangwoo Ryu, Li DiBiopharmaceutics & Drug Disposition|November 2, 2019
The development of a population physiologically based pharmacokinetic model for mycophenolic mofetil and mycophenolic acid in humans using data from plasma, saliva, and kidney tissueMo'tasem M Alsmadi, Mahdi Qasem Alfarah, Jawaher Albderat, et al.Biopharmaceutics & Drug Disposition|July 1, 1991
Stability of diltiazem in different biological fluidsA M McLean, E A Cefali, J S Roden, et al.Pageof 214